Successful treatment of POEMS syndrome complicated by severe congestive heart failure with thalidomide

Internal Medicine

Volumn 49, Issue 5, 2010, Pages 461-466

  Inoue, Daichi ^a   Kato, Aiko ^a   Tabata, Sumie ^a   Kitai, Takeshi ^a   Takiuchi, Yoko ^a   Kimura, Takaharu ^a   Shimoji, Sonoko ^a   Mori, Minako ^a   Nagai, Yuya ^a   Togami, Katsuhiro ^a   Matsushita, Akiko ^a   Nagai, Kenichi ^a   Maruoka, Hayato ^a   Imai, Yukihiro ^a   Beppu, Minako ^a   Kawamoto, Michi ^a   Takahashi, Takayuki ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Congestive heart failure; POEMS syndrome; Thalidomide; VEGF

Indexed keywords

DEXAMETHASONE; MELPHALAN; THALIDOMIDE; VASCULOTROPIN;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; CONGESTIVE HEART FAILURE; CONSTIPATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMANGIOMA; HEPATOSPLENOMEGALY; HUMAN; HYPERTRICHOSIS; LEG EDEMA; NAIL DISEASE; POEMS SYNDROME; PROTEIN BLOOD LEVEL; REPEATED DRUG DOSE; SKIN MANIFESTATION; SYSTOLIC DYSFUNCTION;

ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HUMANS; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POEMS SYNDROME; THALIDOMIDE; TREATMENT OUTCOME;

EID: 77749335693     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2833     Document Type: Article

References (26)

1. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 34: 712-720, 1984.
2. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 101: 2496-2506, 2003.
3. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347: 702, 1996.
4. Feinberg L, Temple D, de Marchena E, Patarca R, Mitrani A. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature. Crit Rev Oncog 10: 293-302, 1999.
5. Dispenzieri A. POEMS syndrome. Blood Rev 21: 285-299, 2007.
6. Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 63: 385-387, 1997.
7. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 66: 105-107, 2006.
8. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 104: 3400-3407, 2004.
9. Sinisalo M, Hietaharju A, Sauranen J, Wirta O. Thalidomide in POEMS syndrome: case report. Am J Hematol 76: 66-68, 2004.
10. Kim SY, Lee SA, Ryoo HM, Lee KH, Hyun MS, Bae SH. Thalidomide for POEMS syndrome. Ann Hematol 85: 545-546, 2006.
11. Kuwabara S, Misawa S, Kanai K, et al. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry 79: 1255-1257, 2008.
12. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317, 2003.
13. Tanus T, Miller HJ. POEMS syndrome presenting with cardiomegaly and cardiomyopathy. J Intern Med 231: 445-448, 1992.
14. Shimizu N, Goya M, Akimoto H, et al. Cardiomyopathy in a case of Crow-Fukase syndrome. Jpn Heart J 38: 877-880, 1997.
15. Ichikawa Y, Nakata T, Ohhata J, et al. Crow-Fukase syndrome with ischemic cardiomyopathy. Intern Med 40: 726-730, 2001.
16. Reitan JB, Pape E, Fosså SD, Julsrud OJ, Slettnes ON, Solheim OP. Osteosclerotic myeloma with polyneuropathy. Acta Med Scand 208: 137-144, 1980.
17. Iwasaki H, Ogawa K, Yoshida H, et al. Crow-Fukase syndrome associated with pulmonary hypertension. Intern Med 32: 556-560, 1993.
18. Manning WJ, Goldberger AL, Drews RE, et al. POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature. Semin Arthritis Rheum 22: 151-161, 1992.
19. Shen H, Clauss M, Ryan J, et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81: 2767-2773, 1993.
20. Senger DR. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 149: 59-71, 1996.
21. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 110: 1075-1076, 2007.
22. Samaras P, Bauer S, Stenner-Liewen F, et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 92: 1438-1439, 2007.
23. Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R. Thalidomide alone or with dexamethasone for previously untreated multiple myeloma. J Clin Oncol 21: 16-19, 2003.
24. Henze T, Krieger G. Combined high-dose 7S-IgG and dexamethasone is effective in severe polyneuropathy of the POEMS syndrome. J Neurol 242: 482-483, 1995.
25. Breitkreutz I, Lokhorst HM, Raab MS, et al. Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield. Leukemia 21: 1294-1299, 2007.
26. Ohwada C, Nakaseko C, Sakai S, et al. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant 43: 739-740, 2009.